Who is sponsoring NCT04629456?

NCT04629456 is sponsored by Cairo University.

What drugs are being tested in NCT04629456?

Interventions in NCT04629456: neuromuscular electric stimulation, Exercises.

What condition does NCT04629456 study?

NCT04629456 studies Liver Cirrhosis, Biliary.

Is NCT04629456 still recruiting?

NCT04629456 is currently completed. Last updated 16 November 2020.

Last reviewed 2020-11-16 · How we verify

NCT04629456

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Therapy for Liver Cirrhosis

Completed NA Last updated 16 November 2020

What this trial tests

NA trial testing neuromuscular electric stimulation in Liver Cirrhosis, Biliary in 60 participants. Completed in 5 June 2020.

Timeline

7 January 2020

Primary endpoint
12 May 2020

5 June 2020

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	7 January 2020
Primary completion	12 May 2020
Estimated completion	5 June 2020
Sites	1 location across Egypt

Drugs / interventions tested

neuromuscular electric stimulation
Exercises

Conditions studied

Liver Cirrhosis, Biliary — all drugs for Liver Cirrhosis, Biliary →

Sponsor

Cairo University

Who can join

Adults 35 to 59, any sex, with Liver Cirrhosis, Biliary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with liver cirrhosis have severe physical deconditioning. Aim: To compare between the effect of neuromuscular electric stimulation(NMES) and exercises (EX)on treatment of patients with liver cirrhosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04629456 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 16 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04629456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing